CA3083663C - Methodes de traitement de la maladie de gaucher - Google Patents

Methodes de traitement de la maladie de gaucher

Info

Publication number
CA3083663C
CA3083663C CA3083663A CA3083663A CA3083663C CA 3083663 C CA3083663 C CA 3083663C CA 3083663 A CA3083663 A CA 3083663A CA 3083663 A CA3083663 A CA 3083663A CA 3083663 C CA3083663 C CA 3083663C
Authority
CA
Canada
Prior art keywords
eliglustat
pharmaceutically acceptable
acceptable salt
patient
cyp2d6
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3083663A
Other languages
English (en)
Other versions
CA3083663A1 (fr
Inventor
Jing Li
M. Judith PETERSCHMITT
Vanaja KANAMALURU
Jun Chen
Sebastiaan J.M. GAEMERS
Dan RUDIN
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority claimed from PCT/US2018/065423 external-priority patent/WO2019118707A1/fr
Publication of CA3083663A1 publication Critical patent/CA3083663A1/fr
Application granted granted Critical
Publication of CA3083663C publication Critical patent/CA3083663C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des méthodes de traitement de la maladie de Gaucher chez des patients atteints d'une insuffisance rénale ou hépatique.
CA3083663A 2017-12-15 2018-12-13 Methodes de traitement de la maladie de gaucher Active CA3083663C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762599467P 2017-12-15 2017-12-15
US62/599,467 2017-12-15
PCT/US2018/065423 WO2019118707A1 (fr) 2017-12-15 2018-12-13 Méthodes de traitement de la maladie de gaucher

Publications (2)

Publication Number Publication Date
CA3083663A1 CA3083663A1 (fr) 2019-06-20
CA3083663C true CA3083663C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2020203874B2 (en) Methods and compositions for treating depression using cyclobenzaprine
KR20170109079A (ko) 피르페니돈 요법의 실시 방법
Marder et al. Brexpiprazole in patients with schizophrenia: overview of short-and long-term phase 3 controlled studies
US20220016101A1 (en) Methods of treating depression, anxiety and sexual dysfunction using the compound pimavanserin
JP2023171774A (ja) ゴーシェ病を処置する方法
CA3083663C (fr) Methodes de traitement de la maladie de gaucher
Azanza et al. Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
US20250073318A1 (en) Mitapivat therapy and modulators of cytochrome p450
Barbour et al. Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant
RU2781242C2 (ru) Способы лечения болезни гоше
WO2022094230A1 (fr) Composés pour le traitement de la psychose ou de la dépression
KR20250069965A (ko) 타시피미딘과 cyp2d6 억제제의 병용 치료
NZ614725B2 (en) Methods and compositions for treating depression using cyclobenzaprine
NZ714294B2 (en) Methods And Compositions For Treating Depression Using Cyclobenzaprine